A Prospective, Randomized Trial to Compare Subtotal Parathyroidectomy Versus Cinacalcet in the Treatment of Persistent Secondary Hyperparathyroidism Post Renal Transplantation.
Phase of Trial: Phase IV
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Cinacalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 05 Oct 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 01 Jul 2011 Planned end date changed from 1 Jan 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 30 Aug 2010 New trial record